Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 66,667 shares at $80.13 ($5.3M) on 2019-05-16, disclosed to the SEC on 2019-05-20.
Open-market sale of $5.3M NBIX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.13 | 731 | $59K | 1.1% |
| 2 | $80.13 | 9,121 | $731K | 13.7% |
| 3 | $80.13 | 22,439 | $1.8M | 33.7% |
| 4 | $80.13 | 34,376 | $2.8M | 51.6% |
| Total | $80.13 avg | 66,667 | $5.3M | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |